Product logins

Find logins to all Clarivate products below.


Trauma Devices | Market Insights | Asia Pacific | 2024

In recent years, the Asia Pacific trauma device market has been negatively impacted by various events, including the COVID-19 pandemic, which diminished procedure volumes at the time, as well as the introduction of the volume-based procurement policy by the Chinese government, which is placing downward pressure on ASPs in the country. Nonetheless, favorable demographics and rising adoption of innovative devices will continue to support overall market growth through 2032.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region from 2019 to 2032.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…